Development and evaluation of extended-release vildagliptin tablets using quality by design
DOI:
https://doi.org/10.69857/joapr.v12i5.735Keywords:
Vildagliptin Extended-release tablets, Co-processed natural polymers, xanthan gum & gum acacia, quality by design approach, Factorial design, Ghost pill effectAbstract
Background: Extended-release dosage forms are designed to enhance patient compliance and decrease dosing frequency. However, commercially available extended-release tablets are made with synthetic or semisynthetic controlled-release polymer, which causes a ghost pill effect. The ghost pill effect is minimized by using natural polymers which are biodegradable. Aim: This study aimed to create extended-release vildagliptin tablets using natural polymer by employing the quality by Design. Method: The study involved preparing granules of vildagliptin by direct compression using co-processed polymer and other excipients and compressing them into tablets. Results & Discussion: The different micromeritic characteristics of granules were satisfactory for compressing them into tablets. The FTIR, DSC, and XRD analysis indicates no interaction between the drug and the other excipients. The drug release shows that the marketed formulation releases 97% of the drug in 8 hrs., Whereas the developed formulation extends the drug release >= 95% throughout 12hrs. Drug release kinetic study results reveal that the optimized batch obeys first-order kinetics with the Higuchi model. In vivo studies showed steady plasma levels over an extended period, achieving the objective of the current study. The stability study carried out as per the ICH guideline exhibited robustness of the formulation, with the drug content found between 96 % to 99 % at 30°C & 75 %RH and 40°C & 75 %RH. Conclusion: The extended-release formulation of vildagliptin could be successfully formulated using a combination of natural and semisynthetic polymers. This combination could prove to be effective, safe, and well tolerated, enhancing patient adherence and lowering overdose risks, thereby reducing overall diabetic treatment costs.
Downloads
References
Chappidi SR, Bhargav E, Marikunte V, Chinthaginjala H, Vijaya Jyothi M, Pisay M, Jutur M, Shaik Mahammad M, Poura M, Yadav S, Syed M. A Cost Effective (QbD) Approach in the Development and Optimization of Rosiglitazone Maleate Mucoadhesive Extended Release Tablets -In Vitro and Ex Vivo. Adv Pharm Bull, 9, 281-8 (2019) https://doi.org/10.15171/apb.2019.032
Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol, 69, 2932-8 (2021) https://doi.org/10.4103/ijo.IJO_1627_21
Sridhar GR, Pandit K, Warrier S, Birla A. Sustained-Release Vildagliptin 100 mg in Type 2 Diabetes Mellitus: A Review. Cureus, 15, e39204 (2023) https://doi.org/10.7759/cureus.39204
Pund A, Mundada A, Magar M, Kadam A. Recent patents on modified release oral dosage forms. Journal of Drug Delivery and Therapeutics, 11, 195-211 (2021) http://dx.doi.org/10.22270/jddt.v11i4-S.4973
Gaikwad SS, Ainor SK, Lande NB, Salunkhe KS. Review of Modified oral solid drug delivery system and recent active Patents. Applied Drug Research, Clinical Trials and Regulatory Affairs, 9, 20-29 (2022) http://dx.doi.org/10.2174/2667337109666221108141059
Bhadane SP, Surawase RK, Jadhav OA, Purkar YS, Shelar SS. Review on recent advances of sustained release matrix tablet. Research Journal of Pharmaceutical Dosage Forms and Technology, 16,189-193 (2024) https://doi.org/10.52711/0975-4377.2024.00030
Mazen A. Ismail, Asim T. Sharif. Case Report: Unexplained presence of yellow oval elements in stool mimicking parasitic infection in a patient on metformin extended-release. Journal of Population Therapeutics and Clinical Pharmacology, 30, 774-776 (2023) https://doi.org/10.53555/jptcp.v30i17.3735
Porte L, Weitzel T. Ghost tablets mimicking intestinal parasite. Braz J Infect Dis, 23, 462-3 (2019) https://doi.org/10.1016/j.bjid.2019.10.006
Overberg A, Purpura A, Nanagas K. "Ghost tablet" husks excreted in feces in large bupropion XL overdose. Clin Toxicol (Phila), 57, 141-2 (2019) https://doi.org/10.1080/15563650.2018.1494276
Surini S, Wati DR, Syahdi RR, editors. Preparation and characterization of cross-linked excipient of coprocessed xanthan gum-acacia gum as matrix for sustained release tablets. Drugs Development, and Medical Devices. AIP Conference Proceedings, 030009-1- 0300010 (2018) https://doi.org/10.1063/1.5023956
Jayswal MG, Sharma V, Siddiqui A, Khan R, Ahmed SA, Shaikh A, Aejazuddin QMA, Khan GJ. Formulation and evaluation of sustained release tablet of an anti-diabetic drug vildagliptin using natural polymer. Int. J. Pharm. Sci, 1(9), 457-468 (2023) https://doi.org/10.5281/zenodo.8394231
Murtale S, Goudanavar P, Acharya A, Lokapur J, Chitti R, Moktan JB. Application of natural and modified polymers in novel drug delivery: A review. Research Journal of Pharmacy and Technology, 14, 6732-6740 (2021) https://doi.org/10.52711/0974-360X.2021.01163
Jagtap K, Chaudhari B, Redasani V. Quality by design (QbD) concept review in pharmaceuticals. Asian Journal of Research in Chemistry, 15, 303-307 (2022) https://doi.org/10.52711/0974-4150.2022.00054
Sikarwar GS, Gupta MK. Formulation development and optimization of fenoprofen floating tablet using QbD approach. Int J. Pharm. Investigation, 14, 76-88 (2024) https://doi.org/10.5530/ijpi.14.1.11
Sopyan I, Gozali D, Kurniawansyah I, Guntina R. Design-expert software (DOE): An application tool for optimization in pharmaceutical preparations formulation. Int. J. Appl. Pharm, 14, 55-63 (2022) https://doi.org/10.22159/ijap.2022v14i4.45144
Thakur S, Pal R, Jha D, Dutta P, Pandey P, Tripathi B, Rizwan M, Ojha S, Singh R. The application of response surface methodology (RSM) in the computational optimization of sustained release (SR) for phenothiazine derivative matrix tablet. J Pharm Res Int, 35, 13-27 (2023). https://doi.org/10.9734/jpri/2023/v35i357483
Akhtar M, Zaman M, Siddiqi AZ, Ali H, Khan R, Alvi MN, Butt MH, Ftama M, Demerdash EL, Binjawhar DN, Sayed AA, Altyar AE, Abdel-Daim MM. Response surface methodology (RSM) approach to formulate and optimize the bilayer combination tablet of Tamsulosin and Finasteride. Saudi Pharm. J, 32, 1-11 (2024) https://doi.org/10.1016/j.jsps.2024.101957
Kumar NR, Rao GK, Ratna JV, Murthy KR. Exploring the potential of neem and tamarind gum as release retardants: Design and statistical optimisation of vildagliptin extended release matrix systems using D-optimal quadratic mixture design. Int. J. Biol, Macromol., 259, 129-136 (2024)
https://doi.org/10.1016/j.ijbiomac.2023.129136
Kausar S, Erum A, Tulain UR, Hussain MA, Farid-ul-Haq M, Malik NS, Rashid A. Formulation, In Vitro Evaluation, and Toxicity Studies of A. vulgaris‐co‐AAm Carrier for Vildagliptin. Adv. Polym. Technol, 2021, 1-17 (2021) https://doi.org/10.1155/2021/6634780
Suzuki Y, Sugiyama H, Kano M, Shimono R, Shimada G, Furukawa R, Mano E, Motoyama K, Koide T, Matsui Y, Kurasaki K, Takayama I, Hikage S, Katori N, Kikuchi M, Sakai H, Matsuda Y. Control strategy and methods for continuous direct compression processes. Asian J. Pharm. Sci, 16, 253-262 (2021).
https://doi.org/10.1016/j.ajps.2020.11.005
Mane SV, Khan MA. Development of UV-Visible spectrophotometric method for the estimation of vildagliptin in different medium. J Pharm Biol Sciences, 10, 83-87 (2022) https://doi.org/10.18231/j.jpbs.2022.016
Damodharan N. Mathematical modelling of dissolution kinetics in dosage forms. Research Journal of Pharmacy and Technology, 13, 1339-145 (2020) https://doi.org/10.5958/0974-360X.2020.00247.4
Alam S, Bishal A, Bandyopadhyay B. Formulaition and evaluation of metformin hydrochloride sustained release tablets. Int J Curr Pharm Res, 13, 82-88 (2021) https://doi.org/10.22159/ijcpr.2021v13i5.1899
Venkatesh DN, Meyyanathan S, Tharik A, Rao S. Formulation and evaluation of sustained release tablets of ramipril. Research Journal of Pharmacy and Technology, 13, 3873-3878 (2020) https://doi.org/10.5958/0974-360X.2020.00685.X
Arafat M, Sarfraz M, Bostanudin MF, Esmaeil A, Salam A, AbuRuz S. In vitro and in vivo evaluation of oral controlled release formulation of bcs class i drug using polymer matrix system. Pharmaceuticals, 14, 1-14 (2021) https://doi.org/10.3390/ph14090929
Prusty A, Gupta BK, Mishra A. Formulation and In vivo evaluation of pharmacokinetics parameters of extended release matrix tablet containing drug benidipine hydrochloride by using PK solver software. Research Journal of Pharmacy and Technology, 15, 4924-4930 (2022) https://doi.org/10.52711/0974-360X.2022.00827
Deepika B, Sujatha K. Design and Evaluation of Vildagliptin Matrix Tablets by Response Surface Methodology.American Journal of Drug Delivery and Therapeutics, 10, 1-18 (2023).
Romley JA, Xie Z, Chiou T, Goldman D, Peters AL. Extended-release formulation and medication adherence. J. Gen. Intern. Med, 35, 354-356 (2020) https://doi.org/10.1007/s11606-019-05275-1
Published
How to Cite
Issue
Section
Copyright (c) 2024 Atul K Pund, Atishkumar S Mundada
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
